Pharmacogenetics in the treatment of chronic lymphocytic leukemia: what does the future hold?

被引：1
|
作者：
Johnson, Gillian G. [1 ,2 ]
Carr, Daniel F. [3 ]
Pirmohamed, Munir [3 ]
Pettitt, Andrew R. [2 ]
机构：
[1] Royal Liverpool & Broadgreen Univ Hosp Trust, Dept Haematol, Liverpool, Merseyside, England
[2] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool L69 3BX, Merseyside, England
[3] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England
来源：
PHARMACOGENOMICS | 2014年 / 15卷 / 07期
基金：
英国医学研究理事会;
关键词：
adverse drug reactions; bendamustine; chronic lymphocytic leukemia; cyclophosphamide; fludarabine; personalized medicine; pharmacogenomics; GENETIC-POLYMORPHISM; UNTREATED PATIENTS; HUMAN LIVER; RITUXIMAB; CYCLOPHOSPHAMIDE; BENDAMUSTINE; CHLORAMBUCIL; FLUDARABINE; EXPRESSION; VARIANTS;
D O I：
10.2217/pgs.14.60
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：897 / 900
页数：4
相关论文
共 50 条
  • [1] Bendamustine in the treatment of chronic lymphocytic leukemia
    Ujjani, Chaitra
    Cheson, Bruce D.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 617 - 623
  • [2] Role of bendamustine in the treatment of chronic lymphocytic leukemia
    Jamshed, Saad
    Cheson, Bruce D.
    ONCOTARGETS AND THERAPY, 2009, 2 : 43 - 49
  • [3] Treatment of Older Patients with Chronic Lymphocytic Leukemia
    Lamanna, Nicole
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2012, 7 (01) : 21 - 25
  • [4] An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Salvaris, Ross
    Opat, Stephen
    FUTURE ONCOLOGY, 2020, 17 (04) : 371 - 387
  • [5] A Canadian Perspective on the First-Line Treatment of Chronic Lymphocytic Leukemia
    Owen, Carolyn
    Bence-Bruckler, Isabelle
    Chamakhi, Ines
    Toze, Cynthia
    Assaily, Wissam
    Christofides, Anna
    Robinson, Sue
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (06): : 303 - 313
  • [6] Bendamustine for treatment of chronic lymphocytic leukemia
    Chang, Julie Elizabeth
    Kahl, Brad Steven
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (10) : 1495 - 1505
  • [7] Choosing first-line therapy for chronic lymphocytic leukemia
    Jaglowski, Samantha
    Jones, Jeffrey A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1379 - 1390
  • [8] PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia
    Chang, Julie E.
    Kahl, Brad S.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (01) : 33 - 43
  • [9] Chronic lymphocytic leukemia: where are we and where are we going?
    Ujjani, Chaitra
    Cheson, Bruce D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (12) : 1675 - 1677
  • [10] Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia
    Niederle, Norbert
    Megdenberg, Dirk
    Balleisen, Leopold
    Heit, Wolfgang
    Knauf, Wolfgang
    Weiss, Johann
    Freier, Werner
    Hinke, Axel
    Ibach, Stefan
    Eimermacher, Hartmut
    ANNALS OF HEMATOLOGY, 2013, 92 (05) : 653 - 660
12345